Study to Evaluate Impact of School-based Influenza Vaccination on School Populations
NCT00844051 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4455
Last updated 2016-09-12
Summary
Rates of confirmed influenza illness in vaccinated and non-vaccinated children will be compared between schools with and without vaccination programs. The investigators hypothesize that in addition to lowering rates of influenza in vaccinated children, raising vaccination rates by 30-40% through school-based vaccination programs will decrease incidence of influenza in non-vaccinated children attending those schools compared to non-vaccinated children in schools with low vaccination rates.
Conditions
Interventions
- BIOLOGICAL
-
School-based influenza vaccination program
School-based influenza vaccination program
Sponsors & Collaborators
-
Los Angeles County Department of Public Health
collaborator OTHER_GOV -
Children's Hospital Los Angeles
lead OTHER
Principal Investigators
-
Pia S Pannaraj, MD, MPH · Childrens Hospital Los Angeles, University of Southern California
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 4 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- United States
Study Locations
More Related Trials
-
Immunologic Response to Influenza Vaccination in Children and Adolescents
NCT03614975 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program
NCT00192218 ·Status: COMPLETED ·Phase: PHASE4
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
NCT05832307 ·Status: RECRUITING ·Phase: NA
-
Study of a Flu Vaccine in Children
NCT00001127 ·Status: COMPLETED ·Phase: PHASE3
-
Direct and Indirect Benefits of Influenza Vaccine Versus Placebo in Healthy Children
NCT00792051 ·Status: COMPLETED ·Phase: NA
-
Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza
NCT01693380 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines
NCT00644059 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.
NCT01964989 ·Status: COMPLETED ·Phase: PHASE3
-
SAVE: School Ambassadors for Vaccine Education
NCT07164144 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
School-located Influenza Vaccination Clinics for Adolescents
NCT03137667 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months
NCT05212623 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets
NCT03898986 ·Status: COMPLETED ·Phase: PHASE1
-
Childhood Influenza Immunisation Invitation Trial in Schools
NCT02883972 ·Status: WITHDRAWN ·Phase: NA
-
Collaborative Efforts to Increase Flu Vaccination
NCT01403649 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
NCT01992107 ·Status: COMPLETED ·Phase: PHASE3
-
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) (Children Forms of Drug)
NCT01551823 ·Status: COMPLETED ·Phase: PHASE3
-
Development of Childhood Anti-Influenza Immunity
NCT03673345 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children
NCT01097941 ·Status: WITHDRAWN ·Phase: PHASE4
-
Direct and Indirect Benefits of Influenza Vaccination in Schools and Households
NCT00981513 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014
NCT01764269 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine
NCT03300050 ·Status: COMPLETED ·Phase: PHASE1
-
Immunologic Response to FluMist vs. Flucelvax
NCT03982069 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIV
NCT01946594 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
NCT00311428 ·Status: COMPLETED ·Phase: PHASE4